← Open Payments lookup

KATIE MCCRARY: Open Payments

NPI 1205457728 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$980 in 50 payments from 9 companies in 2025. Trend: 2023 $470 · 2024 $937 · 2025 $980

Food & beverage: $980
CompanyPaymentsAmount
Novo Nordisk Inc18$401
Otsuka America Pharmaceutical, Inc.12$177
AstraZeneca Pharmaceuticals LP8$150
Bayer Healthcare Pharmaceuticals Inc.5$107
Incyte Corporation2$47
Lilly USA, LLC2$45
TMS NeuroHealth Centers Inc.1$19
Boehringer Ingelheim Pharmaceuticals, Inc.1$18
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$17

Products named: Rybelsus, REXULTI, Kerendia, Ozempic, FARXIGA, JARDIANCE, AIRSUPRA, OPZELURA.

Industry payments across TX — which companies pay providers there.